butylhydroxybutylnitrosamine has been researched along with Disease Exacerbation in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (35.29) | 18.2507 |
| 2000's | 4 (23.53) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Grubbs, CJ; Juliana, MM; Lubet, RA; Miller, MS; Moeinpour, FL; Mohammed, A; Sei, S; Shoemaker, RH; Suen, CS | 1 |
| Eriksson, P; Foth, M; Ismail, NFB; Iwata, T; Knowles, MA; Kung, JSC; Salmond, JM; Sansom, OJ; Sjödahl, G; Tomlinson, D | 1 |
| Fujimoto, K; Gotoh, D; Hori, S; Iida, K; Itami, Y; Miyake, M; Morizawa, Y; Nakai, Y; Onishi, K; Onishi, S; Tanaka, N; Tatsumi, Y | 1 |
| Colaço, A; Costa, C; Lopes, C; Oliveira, PA; Santos, L; Vala, H; Vasconcelos-Nóbrega, C | 1 |
| Chang, C; Chen, CC; Chuang, WM; Hsieh, TF; Hung, XF; Lin, MH; Ma, WL; Shyr, CR; Tsai, YR; Zhang, C; Zhang, Q | 1 |
| Lee, JK; Theodorescu, D; Williams, PD | 1 |
| Chan, KS; Ho, PL; Jian, W; Lay, EJ; Parra, D | 1 |
| Izumi, K; Li, Y; Miyamoto, H | 1 |
| Altieri, DC; Eisenberg, D; Garlick, DS; Plescia, J; Salz, W; Sun, TT; Weiss, RM; Wu, XR | 1 |
| Bucala, R; Claffey, K; Hegde, P; Kuchel, GA; Leng, L; Pilbeam, C; Taylor, JA; Tsimikas, J; Voznesensky, OS | 1 |
| Ito, N; Montesano, R; Ogawa, K; Shibata, MA; Shirai, T; Takahashi, S; Tsuda, H; Wild, CP | 1 |
| Kawabe, M; Orita, SI; Ozaki, M; Shibata, MA; Shirai, T; Takahashi, S | 1 |
| Hirao, Y; Iwai, A; Momose, H; Okajima, E; Ozono, S; Samma, S; Tabata, S; Tsumatani, K; Tsunemi, K; Uemura, H; Yoshida, K | 1 |
| Chen, MT; Huang, CH; Huang, CN; Kuo, KW; Tsai, JL; Wu, WJ | 1 |
| Ariel, I; Ayesh, S; de Groot, N; Elkin, M; Hochberg, A; Schneider, T | 1 |
| Fukushima, S; Ichihara, T; Kishimoto, T; Lee, CC; Sugimura, K; Wada, S; Wanibuchi, H; Yamamoto, S | 1 |
| Delouvée, A; el-Marjou, A; Radvanyi, F; Thiery, JP | 1 |
1 review(s) available for butylhydroxybutylnitrosamine and Disease Exacerbation
| Article | Year |
|---|---|
The role of the androgen receptor in the development and progression of bladder cancer.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Castration; Disease Models, Animal; Disease Progression; Evidence-Based Medicine; Female; Gene Expression Regulation, Neoplastic; Humans; Incidence; Male; Neoplasms, Hormone-Dependent; Receptors, Androgen; Risk Factors; Sex Factors; Signal Transduction; Urinary Bladder Neoplasms | 2012 |
16 other study(ies) available for butylhydroxybutylnitrosamine and Disease Exacerbation
| Article | Year |
|---|---|
Combination of Erlotinib and Naproxen Employing Pulsatile or Intermittent Dosing Profoundly Inhibits Urinary Bladder Cancers.
Topics: Animals; Anticarcinogenic Agents; Butylhydroxybutylnitrosamine; Carcinogens; Disease Progression; Drug Administration Schedule; Drug Therapy, Combination; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Naproxen; Neoplasm Recurrence, Local; Neoplasms, Experimental; Pulse Therapy, Drug; Rats; Time Factors; Time-to-Treatment; Urinary Bladder; Urinary Bladder Neoplasms | 2020 |
FGFR3 mutation increases bladder tumourigenesis by suppressing acute inflammation.
Topics: Animals; Butylhydroxybutylnitrosamine; Cell Transformation, Neoplastic; Cholecystitis, Acute; Disease Models, Animal; Disease Progression; Female; Genetic Predisposition to Disease; Lymphocytes; Male; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Neutrophil Infiltration; Neutrophils; Phenotype; Receptor, Fibroblast Growth Factor, Type 3; Time Factors; Tumor Microenvironment; Urinary Bladder; Urinary Bladder Neoplasms; Urothelium | 2018 |
Intravesical treatment of chemotherapeutic agents sensitizes bacillus Calmette‑Guerin by the modulation of the tumor immune environment.
Topics: Administration, Intravesical; Animals; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Butylhydroxybutylnitrosamine; Carcinoma, Transitional Cell; Disease Progression; Doxorubicin; Female; Humans; Killer Cells, Natural; Macrophages; Mice, Inbred C57BL; Mitomycin; Neoplasm Recurrence, Local; Neoplasms, Experimental; T-Lymphocytes, Regulatory; Treatment Outcome; Tumor Microenvironment; Urinary Bladder; Urinary Bladder Neoplasms | 2019 |
E-cadherin and β-catenin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in mice.
Topics: Animals; beta Catenin; Butylhydroxybutylnitrosamine; Cadherins; Carcinogenesis; Cell Adhesion; Cytoplasm; Disease Progression; Gene Expression Regulation, Neoplastic; Immunohistochemistry; Male; Mice; Mice, Inbred ICR; Phenotype; Prognosis; Urinary Bladder; Urinary Bladder Neoplasms; Urothelium | 2013 |
Epidermal growth factor enhances androgen receptor‑mediated bladder cancer progression and invasion via potentiation of AR transactivation.
Topics: Androgens; Animals; Butylhydroxybutylnitrosamine; Carcinogenesis; Castration; Disease Models, Animal; Disease Progression; Epidermal Growth Factor; ErbB Receptors; Humans; Male; Mice; Mitogen-Activated Protein Kinase Kinases; Phosphatidylinositol 3-Kinases; Quinazolines; Receptors, Androgen; Signal Transduction; Transcriptional Activation; Urinary Bladder Neoplasms | 2013 |
Molecular credentialing of rodent bladder carcinogenesis models.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Disease Models, Animal; Disease Progression; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Mice; Neoplasm Invasiveness; Oligonucleotide Array Sequence Analysis; Rats; Urinary Bladder Neoplasms | 2008 |
Stat3 activation in urothelial stem cells leads to direct progression to invasive bladder cancer.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Disease Progression; Humans; Mice; Mice, Transgenic; STAT3 Transcription Factor; Stem Cells; Urinary Bladder Neoplasms; Urothelium | 2012 |
A survivin gene signature predicts aggressive tumor behavior.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Disease Progression; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Membrane Proteins; Mice; Mice, Transgenic; Microtubule-Associated Proteins; Neoplasm Proteins; Polymerase Chain Reaction; Survivin; Transgenes; Tumor Suppressor Protein p53; Urinary Bladder; Urinary Bladder Neoplasms; Uroplakin II | 2005 |
Null mutation for macrophage migration inhibitory factor (MIF) is associated with less aggressive bladder cancer in mice.
Topics: Animals; Butylhydroxybutylnitrosamine; Disease Progression; Gene Expression; Immunohistochemistry; Intramolecular Oxidoreductases; Macrophage Migration-Inhibitory Factors; Male; Mice; Mice, Knockout; Mutation; Neoplasm Invasiveness; Neoplasm Staging; RNA, Messenger; Urinary Bladder Neoplasms | 2007 |
DNA methylation adduct formation and H-ras gene mutations in progression of N-butyl-N-(4-hydroxybutyl)nitrosamine-induced bladder tumors caused by a single exposure to N-methyl-N-nitrosourea.
Topics: Administration, Oral; Animals; Base Sequence; Butylhydroxybutylnitrosamine; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Deoxyguanosine; Disease Progression; DNA Adducts; DNA Damage; DNA Mutational Analysis; DNA, Neoplasm; Genes, ras; Injections, Intraperitoneal; Male; Methylation; Methylnitrosourea; Molecular Sequence Data; Neoplasm Invasiveness; Polymerase Chain Reaction; Rats; Rats, Inbred F344; Urinary Bladder Neoplasms | 1994 |
Lack of involvement of p53 gene mutations in N-methyl-N-nitrosourea-induced bladder tumor progression in N-butyl-N-(4-hydroxybutyl)nitrosamine-treated rats and no suppression by indomethacin.
Topics: Animals; Anticarcinogenic Agents; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma, Transitional Cell; Cocarcinogenesis; Disease Progression; Genes, p53; Indomethacin; Male; Methylnitrosourea; Mutation; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Rats; Rats, Inbred F344; Urinary Bladder Neoplasms | 1997 |
A histopathological mapping study of the urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in dogs.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma, Papillary; Disease Progression; Dogs; Dose-Response Relationship, Drug; Female; Neoplasm Invasiveness; Urinary Bladder Neoplasms | 1997 |
Changes in the activities of mitochondrial enzymes in the progress of tumorigenesis of bladder cancer.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma, Transitional Cell; Cell Transformation, Neoplastic; Disease Progression; Electron Transport Complex IV; Male; Mitochondria; NADH Dehydrogenase; Rats; Rats, Sprague-Dawley; Succinate Cytochrome c Oxidoreductase; Urinary Bladder; Urinary Bladder Neoplasms | 1998 |
The dynamics of the imprinted H19 gene expression in the mouse model of bladder carcinoma induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Cell Transformation, Neoplastic; Disease Models, Animal; Disease Progression; Epithelial Cells; Female; Gene Expression; Genomic Imprinting; In Situ Hybridization; Mice; Mice, Inbred C3H; Muscle Proteins; Precancerous Conditions; RNA, Long Noncoding; RNA, Untranslated; Urinary Bladder Neoplasms | 1998 |
Reduced expression of the CDK inhibitor p27(KIP1) in rat two-stage bladder carcinogenesis and its association with expression profiles of p21(WAF1/Cip1) and p53.
Topics: Animals; Ascorbic Acid; Butylhydroxybutylnitrosamine; Carcinoma, Transitional Cell; Cell Cycle Proteins; Cell Division; Cocarcinogenesis; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; Disease Progression; Gene Expression Regulation, Neoplastic; Genes, p53; Hyperplasia; Male; Microtubule-Associated Proteins; Neoplasm Proteins; Papilloma; Rats; Rats, Inbred F344; RNA, Messenger; RNA, Neoplasm; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Urinary Bladder Neoplasms; Urothelium | 1999 |
Involvement of epidermal growth factor receptor in chemically induced mouse bladder tumour progression.
Topics: Amphiregulin; Animals; Betacellulin; Butylhydroxybutylnitrosamine; Carcinogens; Disease Progression; EGF Family of Proteins; Epidermal Growth Factor; ErbB Receptors; Gene Expression Regulation, Neoplastic; Glycoproteins; Growth Substances; Heparin-binding EGF-like Growth Factor; Intercellular Signaling Peptides and Proteins; Kidney; Kidney Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Quinazolines; Reverse Transcriptase Polymerase Chain Reaction; Transcription, Genetic; Tyrphostins | 2000 |